BEST PODIUM AND POSTER PRESENTATIONS AWARDED AT ISPOR ANNUAL INTERNATIONAL MEETING

Published May 25, 2016
BEST PODIUM AND POSTER PRESENTATION Washington, DC—May 25, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recognized the Best Podium Presentation and Best Poster Presentation Awardees at its 21st Annual International Meeting this morning in Washington, DC, USA. Best Podium Presentation Awards The Best Podium Presentation Awards were presented by Carl V. Asche, MBA, MSc, PhD, Research Professor of Medicine and Director, Center for Outcomes Research, University of Illinois College of Medicine at Peoria, Peoria, IL, USA. Best General Podium Presentation Awards
  • ME2 - MEDICARE PART D COST SHARING AND SPECIALTY DRUG INITIATION IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS Doshi JA1, Li P1, Huo H1, Pettit AR1, Kumar R1, Huntington SF2, Weiss BM3 1University of Pennsylvania, Philadelphia, PA, USA, 2Yale University, New Haven, CT, USA, 3Hospital of the University of Pennsylvania, Philadelphia, PA, USA
  • CE2 - COST EFFECTIVENESS OF ADDING CLOSTRIDIAL COLLAGENASE OINTMENT TO STANDARD OF CARE IN INDIVIDUALS WITH STAGE IV PRESSURE ULCERS Carter M1, Gilligan A2, Waycaster CR3, Schaum K4 1Strategic Solutions Inc., Cody, WY, USA, 2Truvan Health Analytics, Ann Arbor, MI, USA, 33Smith & Nephew Inc., Fort Worth, TX, USA, 4Smith & Nephew Inc., Lake Worth, FL, USA
  • MA2 - HEALTH CARE EXPENDITURES ASSOCIATED WITH PERSISTENT EMERGENCY DEPARTMENT USE: A MULTI-STATE ANALYSIS OF MEDICAID BENEFICIARIES Agarwal P1, Bias T1, Sambamoorthi U2 1West Virginia University, Morgantown, WV, USA, 2West Virginia University, School of Pharmacy, Morgantown, WV, USA
Best Student Podium Presentation Awards
  • SY4 - ECONOMIC EVALUATION OF AN AUTOMATED RETINAL IMAGE ANALYSIS IN AUSTRALIAN ABORIGINAL AND TORRES STRAIT ISLANDER POPULATIONS FOR DETECTION OF DIABETIC RETINOPATHYY Ballreich J1, Burnett A2, Frick K1, Ho A2, Arkapaw L2, Kleinert A2 1Johns Hopkins University, Baltimore, MD, USA, 2Brien Holden Vision Institute and Vision Cooperative Research Centre, Sydney, Australia
  • BI2 - ESTIMATING THE COSTS OF SUPPORTING SAFETY-NET TRANSFORMATION INTO PATIENT-CENTERED MEDICAL HOMES IN POST-KATRINA NEW ORLEANS Camponeschi GF1, Bridges JF2, Danoff SK1, Richardson B1 Shao H1, Shi L1, Diana M1, Brown L2, Mason K2, Cocran D2, Carruth A2, Schmidt L3 1Tulane University, New Orleans, LA, USA, 2Louisiana Public Health Institute, New Orleans, LA, USA, 3University of California at San Francisco, San Francisco, CA, USA
  • CO3 - COMPARATIVE EFFECTIVENESS OF PANITUMUMAB VERSUS CETUXIMAB IN PATIENTS WITH CHEMO-REFRACTORY WILD-TYPE KRAS METASTATIC COLORECTAL CANCER Xu Y, Hay JW, Barzi A University of Southern California, Los Angeles, CA, USA
Best New Investigator Podium Research Presentations
  • CN1 - THE POTENTIAL CLINICAL, RESOURCE USE, AND FISCAL IMPACTS OF LUNG-RADS TO INFORM LUNG CANCER SCREENING IN MEDICARE Roth J1, Sullivan SD2, Ramsey S1, Goulart B1 1Fred Hutchinson Cancer Research Center, Seattle, WA, USA,2University of Washington, Seattle, WA, USA
  • CV2 - EFFECTIVENESS AND SAFETY OF REDUCED DOSE NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN PATIENTS WITHOUT SEVERE RENAL IMPAIRMENT Yao X, Shah ND, Sangaralingham LR, Gersh BJ, Noseworthy PA Mayo Clinic, Rochester, MN, USA
  • PR2 - GENERIC INJECTABLE SHORTAGES AND TRENDS IN AVERAGE SALES PRICE IN THE UNITED STATES Hur P1, Ray D2, Vegesna A3, Obi EN2 1University of Maryland School of Pharmacy, Baltimore, MD, USA,2Rutgers University, Piscataway, NJ, USA, Jefferson College of Population Health, Philadelphia, PA, USA
BEST POSTER RESEARCH PRESENTATION AWARDS The Best Poster Presentation Awards were presented by Rajender R. Aparasu, PhD, Professor and Department Chair, University of Houston, Houston, TX, USA.  Best General Poster Research Presentations
  • PMS38 - HEALTH CARE RESOURCE UTILIZATION AND DIRECT MEDICAL COST FOR INPATIENTS WITH OSTEOPOROTIC FRACTURE IN TIANJIN, CHINA Qu Y1,Wang K2, Chen Y2, Wu J1 1Tianjin University, Tianjin, China, 2Lilly Suzhou Pharmaceutical Company, Ltd., Shanghai, China
  • PIN38 - EXPLORING THE COST-EFFECTIVE THRESHOLD PRICE OF DENGUE VACCINATION PROGRAMS IN MALAYSIA: A VALUE-BASED PRICING ASSESSMENT Yeo HY1, Shafie AA1, Coudeville L2, Steinberg LD3, Gill BS4, Jahis R4 1Universiti Sains Malaysia, Penang, Malaysia,2Sanofi Pasteur, Lyon, France, 3Sanofi Pasteur, Petaling Jaya, Malaysia,4Ministry of Health Malaysia, Wilayah Persekutuan Putrajaya, Malaysia
  • PHS32 - CLINICAL AND ECONOMIC BURDEN OF BLOODSTREAM INFECTIONS FOLLOWING CENTRAL VENOUS CATHETER PLACEMENT IN THE INTENSIVE CARE UNIT Brunelli SM1, Turenne W1, Sibbel S1, Hunt A1, Pfaffle A2 1DaVita Clinical Research, Minneapolis, MN, USA,2CorMedix Inc, Bedminster, NJ, USA
Best Student Poster Research Presentations
  • PIN38 - EXPLORING THE COST-EFFECTIVE THRESHOLD PRICE OF DENGUE VACCINATION PROGRAMS IN MALAYSIA: A VALUE-BASED PRICING ASSESSMENT Yeo HY1, Shafie AA1, Coudeville L2, Steinberg LD3, Gill BS4, Jahis R4 1Universiti Sains Malaysia, Penang, Malaysia,2Sanofi Pasteur, Lyon, France, 3Sanofi Pasteur, Petaling Jaya, Malaysia,4Ministry of Health Malaysia, Wilayah Persekutuan Putrajaya, Malaysia
  • PMH39 - COST EFFECTIVENESS OF LURASIDONE, QUETIAPINE, AND OLANZAPINE MONOTHERAPY IN THE TREATMENT OF BIPOLAR I DISORDER DEPRESSION Bhagvandas NS, Hay JW University of Southern California, Los Angeles, CA, USA
  • PCN203 - EVALUATION OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER: SYSTEMATIC REVIEW AND TRIAL LEVEL META-ANALYSIS Adunlin G1, Dranitsaris G2 1Virginia Commonwealth University, Richmond, VA, USA,2Augmentium Pharma Consulting Inc., Toronto, ON, Canada 
Best New Investigator Poster Research Presentations
  • PHS102 - CHARACTERIZING EMERGENCY DEPARTMENT UTILIZATION AMONG PEDIATRIC PATIENTS WITH TYMPANOSTOMY TUBES Tam IM1, Candrilli SD2, Moss JR3 1Otonomy, Inc., San Diego, CA, USA,2RTI Health Solutions, Research Triangle Park, NC, USA, 3Charlotte Eye, Ear, Nose, and Throat Associates, Matthews, NC, USA
  • PRM106 - VALUE OF INFORMATION METHODS FOR OPTIMAL TIMING OF BIOMARKER COLLECTION Bansal A, Basu A University of Washington, Seattle, WA, USA
  • PRS55 - RELATIONSHIP BETWEEN SEVERITY AND ACUTE INHALER USE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE Hur P1, Albrecht J2, Huang T3, Simoni-Wastila L3, Moyo P3, Khokhar B3, Harris I4, Wei Y5 1University of Maryland School of Pharmacy, Baltimore, MD, USA,2Univeristy of Maryland, School of Medicine, Baltimore, MD, USA, 3Univeristy of Maryland, School of Pharmacy, Baltimore, MD, USA, 4Impaq International, Columbia, MD, USA,5University of Florida College of Pharmacy, Gainesville, FL, USA

###

Related Stories

ISPOR Announces 2025-2026 Board of Directors

May 20, 2025

ISPOR announced the results of its recent elections and its 2025-2026 Board of Directors. The 2025-2026 board will assume office on July 1.

Value in Health Journal Spotlights "Whole Health" in Special Series

May 19, 2025

Value in Health, the official journal of ISPOR, announced the publication of a series of articles exploring the concept of "whole health"—a holistic approach to healthcare that extends beyond the traditional biomedical model to incorporate physical, mental, social, environmental, and spiritual dimensions of wellbeing.

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×